Cancer Therapy

Edited by : Neeraja Sankaran C. Fleming, J.H. Wasson, P. Albertsen, M.J. Barry, J. E. Wennberg, "A decision analysis of alternative treatment strategies for clinically localized prostate cancer," Journal of the American Medical Association, 269:2650-8, 1993. (Cited in 88 publications through January 1995) Comments by Craig Fleming, HealthOutcomes Associates, Vancouver, Wash. This evaluation of the relative efficacy of therapies for localized prostate cancer is part of a multi-institutional st

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by : Neeraja Sankaran
C. Fleming, J.H. Wasson, P. Albertsen, M.J. Barry, J. E. Wennberg, "A decision analysis of alternative treatment strategies for clinically localized prostate cancer," Journal of the American Medical Association, 269:2650-8, 1993. (Cited in 88 publications through January 1995)

Comments by Craig Fleming, HealthOutcomes Associates, Vancouver, Wash.

This evaluation of the relative efficacy of therapies for localized prostate cancer is part of a multi-institutional study by the Prostate Patient Outcomes Research Team (Prostate PORT) at Dartmouth College Medical School and Harvard Medical School. "The paper has received so much attention because it raises some very controversial issues regarding present treatments for prostate cancer," declares Craig Fleming, a former assistant professor of medicine at Dartmouth and currently president of Health Outcomes Associates in Vancouver, Wash.

"Prostate cancer is one of the most common cancers among men in this country, and currently 35,000 men die each year with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies